First Time Loading...

iSpecimen Inc
NASDAQ:ISPC

Watchlist Manager
iSpecimen Inc Logo
iSpecimen Inc
NASDAQ:ISPC
Watchlist
Price: 0.263 USD -1.31% Market Closed
Updated: May 4, 2024
ISPC
/
Income Statement
/
Revenue

iSpecimen Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

iSpecimen Inc
Revenue Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
CERT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
iSpecimen Inc
NASDAQ:ISPC
Revenue
$9.9m
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Revenue
$2.4B
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
27%
Inspire Medical Systems Inc
NYSE:INSP
Revenue
$624.8m
CAGR 3-Years
76%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Revenue
$2B
CAGR 3-Years
29%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Revenue
$419.1m
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Certara Inc
NASDAQ:CERT
Revenue
$354.3m
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
N/A

iSpecimen Inc
Revenue Breakdown

Breakdown by Geography
iSpecimen Inc

Not Available

Breakdown by Segments
iSpecimen Inc

Total Revenue: 9.9m USD
100%
Specimens: 9.4m USD
94.3%
Shipping And Other: 566.5k USD
5.7%

See Also

What is iSpecimen Inc's Revenue?
Revenue
9.9m USD

Based on the financial report for Dec 31, 2023, iSpecimen Inc's Revenue amounts to 9.9m USD.

What is iSpecimen Inc's Revenue growth rate?
Revenue CAGR 5Y
18%

Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for iSpecimen Inc have been 7% over the past three years , 18% over the past five years .

ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.